IP
IndiaPulse

Supreme Petrochem Limited (SPLPETRO)

Large Cap

Chemicals stocks · Large cap · NSE

Supreme Petrochem Limited manufactures polystyrene and other styrenic products. It operates an ABS plant and is expanding its EPS capacity. The company focuses on both OEM and non-OEM segments, maintaining a debt-free balance sheet and funding capex through internal accruals.

₹771.05
+45.25 · +6.23%
Quote04 Sept, 03:59 pm IST
Fundamentals05 Sept 2026 · screener
Score05 Sept, 10:20 pm IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 34.2 (n=45)
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Mixed fundamentals, management trust is supportive, price trend is neutral, and recent execution is mixed.

Suggested next step
Research, do not rush
The four lenses are not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
FAIR VALUE
49

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Healthy Trust
76

low confidence · 0/0 claims checked

Technical
Bullish
60

Timing lens: price trend and sector relative strength.

Result consistency
mixed
55

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 30 Jun 2026

Excellent · 100/100

Rev +22% YoY · PAT +190% YoY · margin expansion · +7% QoQ · operating leverage

Filed 27 Jul 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹1,715 Cr+22.3%+6.8%
EBITDA₹332 Cr+186.2%+30.2%
Operating margin19.0%+1100 bps+300 bps
PAT₹238 Cr+190.2%+40.8%
PAT margin13.9%+803 bps+336 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business & thesis

Growth engines, tailwinds/headwinds, and risk radar from management commentary

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-06-03T18:39:15.576Z
Management commentary snapshot

Q4 FY26 revenue grew 3% YoY to INR 1,587 crores, driven by higher volumes and better spreads. Operating EBITDA surged 75% YoY to INR 253 crores, with margins improving to 15.9%. FY26 revenue declined 11% YoY due to lower styrene monomer prices, but volumes grew 2%.

Q4 FY26 showed strong operational performance with significant EBITDA growth and margin expansion, driven by higher volumes and better spreads. Full-year revenue was impacted by lower raw material prices, but volume growth was maintained. Capacity expansions and new product ramp-ups are key for future growth, though raw material volatility and non-OEM demand softness pose near-term challenges.

Growth engines

ABS Plant Ramp-up

Maas ABS plant restarted with modified arrangements, operating at 65% capacity. Product has been well accepted in the market.

EPS Phase-II Expansion

Successfully commissioned on April 14, 2026, enhancing EPS capacity from 85,000 TPA to 115,000 TPA at Amdoshi complex.

Xmold Division Growth

Expects 50-60% more volume this year, targeting 65-70% utilization. Onboarded two AC manufacturers in Sri City.

Specialized Grades

Value-added grades for refrigerators and ACs provide better profitability, with the company present across various user segments.

Capacity and execution

EPS Phase-II Expansion

Successfully commissioned on April 14, 2026, enhancing EPS capacity from 85,000 TPA to 115,000 TPA at Amdoshi complex.

Maas ABS Plant Capacity

Original capacity 70,000 TPA, currently operating at 65% of design capacity (effectively 45,000 TPA) due to impacted equipment.

FY27 CAPEX Plan

Company plans around INR 250 crores for FY27, mainly for infrastructure and other related activities, not PS/EPS projects at Panipat yet.

Tailwinds

Healthy OEM Demand

Demand from OEM segments remained healthy during Q4 FY26.

Strong EPS Demand Segments

Demand growth for EPS came from packing, construction, and cold storage segments last year.

Domestic Demand Fulfillment

Company was able to meet domestic demand through sufficient inventory, material in transit, and sourcing from alternate geographies.

Headwinds

Raw Material Price Volatility

Styrene monomer prices increased sharply in March 2026 due to West Asia conflict and supply disruption through Strait of Hormuz.

Non-OEM Demand Softness

Non-OEM segments witnessed some softness in Q4 and demand has taken a big beating in April due to high prices, labor, and gas shortages.

Supply Chain Disruption

West Asia conflict impacted Middle East shipments, increasing shipping time and freight rates, making exports challenging.

Risk radar

Inventory Losses

Management is aware that inventory loss might come the moment the situation normalizes and prices drop.

Geopolitical Instability

West Asia conflict directly impacts raw material supply, costs, and global shipping, creating a very dynamic and fluid situation.

OEM Contract Delays

Company is not entering into new contracts with OEMs due to the fluid situation in raw material pricing and freight costs.

Management accountability

What management said, and what results must prove

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare BOTH

Q4 results are compared YoY to assess performance against a typically strong seasonal quarter. Full-year results are also compared YoY to understand the overall trend despite raw material price fluctuations.

Sector KPIs management disclosed

Q4 FY26 Sales Volume (manufactured products)

Increased to 100,664 tons in Q4 FY26, reflecting a growth of about 5.4% compared to 95,556 tons in Q4 FY25.

FY26 Sales Volume (manufactured products)

Stood at 363,203 metric tons, reflecting a growth of about 2% compared to 355,967 metric tons in FY25.

FY26 Capacity Utilization

Remained healthy at over 80% for the year.

Q4 FY26 Operating EBITDA Margin

Improved to 15.9% from 9.4% in Q4 FY25.

Management forward view

FY27 Volume Growth Outlook

Expects 8-10% volume growth in FY27 if normalcy returns by June end (Q2 onwards), subject to global situation.

ABS Phase-II Timeline

Still aiming for FY28 commissioning for the second ABS line, irrespective of current Phase-I equipment issues.

Panipat Project Delay

PS and EPS projects at Panipat are delayed, pending more clarity on IOC's styrene monomer plant commissioning date.

Financial Strength

Company remains debt-free with an investable surplus of INR 700 crores as of March 2026, funding all capex through internal accruals.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Styrene Monomer (SM) PricesAround $1,500/ton, after peaking at $1,650/ton in March.Stabilization and moderation of SM prices, and easing of supply chain disruptions from West Asia.
Maas ABS Plant Utilization65% of design capacity (effectively 45,000 TPA) due to impacted equipment.Restoration of the impacted equipment and ramp-up to 100% of original capacity (70,000 TPA).
Non-OEM Demand RecoverySubdued in April due to high prices, labor unavailability, and gas shortages.Signs of recovery in non-OEM demand as raw material prices stabilize and other market conditions improve.
FY27 Volume GrowthManagement expects 8-10% growth if normalcy returns by Q2 FY27.Actual volume growth achievement, especially given Q1 headwinds and ABS plant operational status.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Technical timing lens

Trend score and candlestick chart

60Bullish

SMA20 -1.2% / mo · MACD +

Stock trend: 61
Sector RS: 57
Sector 3M: +0.0% vs Nifty -1.5%

Technical chart

SPLPETROdaily · 1Y · AUTO+13.4%
Latest close ₹771.05 on 2026-09-04
Bar
+6.4%
RSI
67
MACD hist
6.09
52W pos
60%
2026-09-04O ₹725.00H ₹783.00L ₹724.95C ₹771.05Vol 17.3L sh
₹620.67₹679.95₹739.23₹798.50₹857.78771.052026-032026-06VolRSIMACD2026-032026-042026-062026-072026-09
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal

Daily technical trend read

Mixed signals

Signals are conflicting — long-term uptrend intact. RSI 67. Wait for confirmation.

  • Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
  • SMA20 falling (~1.2% over last month) — short-term momentum negative.
  • RSI(14) at 67 — rising, no extreme reading.
  • MACD above signal, histogram expanding — bullish momentum building.
  • 21% off 52W high · 67% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

56
RS percentile
Stage 2 Uptrend
1M return
+9.9%
3M return
+13.9%
6M return
+11.7%
1Y return
-4.1%
RS 1D
+10
RS 20D
+18
Sector rank
#11
Industry rank
-
Stage evidence
  • Price is 8.8% above the 30-week proxy.
  • The 50-DMA is above the 30-week proxy and its slope is rising +3.1%.
  • Both 3-month and 6-month returns are positive.
50-DMA
price above
200-DMA
price above
Sector
neutral
Industry
unranked
Relative-strength line vs Nifty 500 (base 100)
264 observations
04 Sept 2026Value 102.69+6.24%
668094107121Aug 25Dec 25Apr 26Sept 26103
RS vs Nifty 500103

Valuation & score drivers

U-Score 49 · FAIR VALUE · pillar breakdown, sector model, fair-value anchor

49U-SCORE
Financial Turnaround

Fundamental score breakdown

FAIR VALUE
Valuation8/30
Growth14/25
Quality4/20
Balance Sheet12/15
Cash Flow6/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
49

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

49/100 · FAIR VALUE

Positive drivers

  • Piotroski is strong at 8/9.
  • Fair-value margin of safety is positive at 33.5%.
  • Balance sheet contributes 12/15 to the score.

Main drags

  • Quality is weaker at 4/20; verify the latest quarterly trend.
  • Valuation is weaker at 8/30; verify the latest quarterly trend.
  • Growth is weaker at 14/25; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
29.5
PB
6.1
EV/EBITDA
17.4
ROE
13.7%
ROCE
FCF Yield
0.4%
Debt/Equity
0.1
MoS
+33.5%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 05 Sept 2026
v4.3-runtime-valuation
Final score
49
Previous: 49
Verdict
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
+33.5%
Previous: +33.5%

Score history

12 stored score snapshots. Latest stored move: +0 points.

05 Sept 2026
v4.3-runtime-valuation
36
36
47
47
47
47
47
47
47
49
49
49

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹270.34
-185.2% MoS
Growth-justified P/E
45.0
Growth-justified Value
₹1,160.1
+33.5% MoS
PEG
1.68

Trust score

Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth

Trust Score
76Healthy Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Healthy Trust: Claim history is still being built. It ranks around the 81st percentile of the scored universe and 70th percentile within Chemicals. Main check: results consistency is weak at 55/100.

High Trust Lite: Promoter holding is 64.2%. Key concern: ROCE trend is -20%.

Computed 05 Sept 2026
management-trust-v1
73 docs text-extracted · 29 concalls text-extracted
Score band
Healthy Trust

Generally investable credibility. Look for weak sub-scores before increasing position size.

Relative rank
81st percentile

overall median 67 · Chemicals: 70th pctile, median 73 · Large: 62nd pctile, median 73

Evidence depth
Financial-only

73 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Healthy Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
58
watch · capital discipline
Results
55
watch · quarterly consistency

Trust positives

  • Promoter holding is 64.2%.
  • Promoter pledge is zero.
  • FCF yield is positive at 0.4%.
  • 6 years of positive FCF.

Trust risks

  • ROCE trend is -20%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Financials

Full fundamentals table and 10-year revenue / profit / ROE history

Fundamentals

Valuation

P/E
29.50
P/B
6.12
EV/EBITDA
17.44
Market Cap
14499.00Cr

Profitability

ROE
13.70%
ROCE
ROA
13.90%
Dividend Y
1.36%

Growth (CAGR)

Revenue 5Y
18.00%
EPS 5Y
18.00%
Revenue 3Y
17.00%
EPS 3Y
17.00%

Balance Sheet

Debt/Equity
0.06
Interest Coverage
49.13×
Altman Z
9.52
Book Value
126.00

Cash Flow

FCF Yield
0.39%
FCF Positive Y
6/5
OCF
247.00 Cr
EPS TTM
25.78

Shareholding

Promoter Hold
64.24%
Promoter Pledge
0.00%
Momentum 52W
60%

Financial History

Updated 5/9/2026

Revenue

₹ Cr
Latest: 5,406+235.2% vs prev
05406Jun 2006: 1,432Jun 2007: 1,493Jun 2008: 1,483Jun 2009: 1,395Jun 2010: 1,613Mar 2026: 5,406Q1 06Q1 07Q1 08Q1 09Q1 10FY26

Net Profit

₹ Cr
Latest: 330+450.0% vs prev
0330.0Jun 2006: 17.0Jun 2007: 32.0Jun 2008: 23.0Jun 2009: 19.0Jun 2010: 60.0Mar 2026: 330Q1 06Q1 07Q1 08Q1 09Q1 10FY26

Return on Equity

%
Latest: 13.9-45.2% vs prev
025.3Jun 2006: 11.0%Jun 2007: 18.2%Jun 2008: 12.2%Jun 2009: 9.6%Jun 2010: 25.3%Mar 2026: 13.9%Q1 06Q1 07Q1 08Q1 09Q1 10FY26

Peers

Business-comparable names in Chemicals, ranked by similarity

Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.